Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2009-11-16
Original SEC Filing: Click here

---

Webplus: SKBI/20091116/8-K/2_EX-99.1/000.htm SEC Original: v166480_ex99-1.htm
Skystar Bio-Pharmaceuticalmpany Announces Third Quarter 2009 Financial Resultsmpany Reports Record Quarterly Revenue of $12.78 Million andjusted Netome of $4.25 Million; andjusted EPS of $0.61 Per Share XI’AN, CHINA November 16, 2009ystar Bio-Pharmaceuticalmpany (NASDAQ:BI) THIRD QUARTER 2009 HIGHLIGHTS Revenuereased 27.1% period over period to $12.78 million.

---

---

Webplus: SKBI/20091116/8-K/1/000.htm SEC Original: v166480_8k.htm
FORM 8-K CURRENT REPORTte of report (Date of earliest event reported): November 16, 2009YSTAR BIO-PHARMACEUTICALMPANY Nevada 000-28153 33-0901534 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian, Shaanxi Province, P.R. China

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2009-11-16CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE